Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: DNA X(SONM) the EBIT is -3.618 M (-315.9%);the EPS is 5.01 (+255%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B315.86%
----
----
EPS
5.0116255.00%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf